Evidence map›Paper›PMID 29216317›Full record

ArticlePLoS pathogens2017

Novel Wolbachia-transinfected Aedes aegypti mosquitoes possess diverse fitness and vector competence phenotypes.

Johanna E Fraser, Jyotika Taneja De Bruyne, Iñaki Iturbe-Ormaetxe, Justin Stepnell, Rhiannon L Burns, Heather A Flores, Scott L O'Neill

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Research Trends and Collaborative Patterns inInternational journal of environmental research and public health · 2026
    Article
  4. Review
  5. Review
  6. New microbes and new infections · 2025
    Review
  7. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  8. Development of the Incompatible Insect Technique targetingApplied and environmental microbiology · 2025
    Article
  9. Applied and environmental microbiology · 2025
    Article
  10. Article
  11. Life table variations inFrontiers in insect science · 2025
    Article
  12. Review
  13. Microbiology spectrum · 2024
    Article
  14. AntiviralmBio · 2024
    Article
  15. Article
  16. Article
  17. Detection of Natural Wolbachia Strains in Anopheles Mosquitoes.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  18. Detection and quantification of naturalFrontiers in cellular and infection microbiology · 2024
    Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Johanna E FraserInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0002-8020-2985
Jyotika Taneja De BruyneInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-1993-7381
Iñaki Iturbe-OrmaetxeInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.
Justin StepnellInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.
Rhiannon L BurnsInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-4410-9377
Heather A FloresInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0001-5003-7547
Scott L O'NeillInstitute of Vector-Borne Disease, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0002-4131-3615

Funding

Wellcome Trust
6 · The paper itself

Abstract

Wolbachia pipientis from Drosophila melanogaster (wMel) is an endosymbiotic bacterium that restricts transmission of human pathogenic flaviviruses and alphaviruses, including dengue, Zika, and chikungunya viruses, when introduced into the mosquito vector Aedes aegypti. To date, wMel-infected Ae. aegypti have been released in field trials in 5 countries to evaluate the effectiveness of this strategy for disease control. Despite the success in establishing wMel-infected mosquitoes in wild populations, and the well-characterized antiviral capabilities of wMel, transinfecting different or additional Wolbachia strains into Ae. aegypti may improve disease impact, and perhaps more importantly, could provide a strategy to account for the possible evolution of resistant arboviruses. Here, we report the successful transinfection of Ae. aegypti with the Wolbachia strains wMelCS (D. melanogaster), wRi (D. simulans) and wPip (Culex quinquefasciatus) and assess the effects on Ae. aegypti fitness, cytoplasmic incompatibility, tissue tropism and pathogen blocking in a laboratory setting. The results demonstrate that wMelCS provides a similar degree of protection against dengue virus as wMel following an infectious blood meal, and significantly reduces viral RNA levels beyond that of wMel following a direct challenge with infectious virus in mosquitoes, with no additional fitness cost to the host. The protection provided by wRi is markedly weaker than that of wMelCS, consistent with previous characterisations of these lines in Drosophila, while wPip was found to substantially reduce the fitness of Ae. aegypti. Thus, we determine wMelCS as a key candidate for further testing in field-relevant fitness tests and viremic blood feeding challenges in a clinical setting to determine if it may represent an alternative Wolbachia strain with more desirable attributes than wMel for future field testing.

Indexed as

AedesAnimalsCommunicable Disease ControlCulexDengue VirusDrosophila melanogasterDrosophila simulansFemaleFertilityInfectious Disease Transmission, VerticalMaleMosquito ControlMosquito VectorsOrgan SpecificityOvaryRNA, ViralRNA, Viral

Identifiers

PMID29216317
PMCPMC5736235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.